Research Article

Using the Spleen as an In Vivo Systemic Immune Barometer Alongside Osteosarcoma Disease Progression and Immunotherapy with α-PD-L1

Table 5

Population distribution comparison of LLCs isolated from the spleens of mice from TF tumor-bearing (n = 5) and SH (n = 4) groups.

PopulationTF % expression/TCESSH % expression/TCESp

NK cells10.78 ± 4.5%1.85 ± 0.4%0.006
CTLs2.73 ± 1.22%3.72 ± 0.86%0.21
Ths6.45 ± 3.08%7.72 ± 1.1%0.46
Tregs21.09 ± 5.12%7.25 ± 0.23%0.0011
CTLA-4+ CTLs18.35 ± 10.12%1.72 ± 0.42%0.014
TCES18.23 ± 4.580.16 ± 0.0540.0001

The statistics for each group are summarized accordingly with significance being assigned to those populations presenting values < 0.0083 from a two-tailed Student’s T-test with Bonferroni correction and 95% confidence as denoted by an asterisk. LLC = lymphoid lineage cell; TF = transfected; NK = natural killer; CTL = cytotoxic T lymphocyte; Th = T helper cell; Treg = T regulatory cell; CTLA-4+ CTL = cytotoxic T-lymphocyte-associated protein 4 positive cytotoxic T lymphocyte; TCES = T-cell exhaustion status.